全文获取类型
收费全文 | 61274篇 |
免费 | 5830篇 |
国内免费 | 3408篇 |
专业分类
耳鼻咽喉 | 511篇 |
儿科学 | 875篇 |
妇产科学 | 1005篇 |
基础医学 | 7022篇 |
口腔科学 | 1080篇 |
临床医学 | 7188篇 |
内科学 | 9882篇 |
皮肤病学 | 738篇 |
神经病学 | 2914篇 |
特种医学 | 2576篇 |
外国民族医学 | 34篇 |
外科学 | 7354篇 |
综合类 | 9151篇 |
现状与发展 | 15篇 |
一般理论 | 16篇 |
预防医学 | 3994篇 |
眼科学 | 1486篇 |
药学 | 6530篇 |
52篇 | |
中国医学 | 3093篇 |
肿瘤学 | 4996篇 |
出版年
2024年 | 172篇 |
2023年 | 843篇 |
2022年 | 2079篇 |
2021年 | 2857篇 |
2020年 | 2072篇 |
2019年 | 1890篇 |
2018年 | 2033篇 |
2017年 | 1815篇 |
2016年 | 1798篇 |
2015年 | 2504篇 |
2014年 | 3180篇 |
2013年 | 3192篇 |
2012年 | 4468篇 |
2011年 | 4752篇 |
2010年 | 3097篇 |
2009年 | 2547篇 |
2008年 | 3390篇 |
2007年 | 3449篇 |
2006年 | 3187篇 |
2005年 | 2982篇 |
2004年 | 2403篇 |
2003年 | 2219篇 |
2002年 | 2006篇 |
2001年 | 1666篇 |
2000年 | 1602篇 |
1999年 | 1440篇 |
1998年 | 774篇 |
1997年 | 780篇 |
1996年 | 631篇 |
1995年 | 530篇 |
1994年 | 463篇 |
1993年 | 313篇 |
1992年 | 506篇 |
1991年 | 412篇 |
1990年 | 388篇 |
1989年 | 345篇 |
1988年 | 274篇 |
1987年 | 260篇 |
1986年 | 205篇 |
1985年 | 160篇 |
1984年 | 117篇 |
1983年 | 84篇 |
1982年 | 60篇 |
1981年 | 73篇 |
1980年 | 39篇 |
1979年 | 72篇 |
1978年 | 37篇 |
1974年 | 36篇 |
1973年 | 33篇 |
1972年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Yang Lü Wei Liu Hui Liang Shulong Zhao Wei Zhang Jia Liu Cheng Jin Hongyan Hu 《Diagnostic microbiology and infectious disease》2018,90(2):153-155
A carbapenemase-producing Enterobacter cloacae hhy03 with a blaNDM-1 and blaSHV-12-coharboring plasmid was isolated from a sputum specimen of a patient. This is the third nucleotide sequence report of blaNDM-1-harboring plasmid from Enterobacter cloacae that have caused lethal infections in China, indicating the spread of NDM-1 by IncX3 plasmid between Enterobacteriaceae. 相似文献
992.
993.
Chi Yuen Cheung Man Fai Lam Kai Ming Chow William Lee Yuk Lun Cheng Sze Kit Yuen 《Renal failure》2014,36(6):865-869
Kidney transplant recipients have increased risk of cancers when compared with the general population. Hepatocellular carcinoma (HCC) is extremely important in Asia where hepatitis B virus (HBV) infection is endemic. The aim is to study the epidemiological and clinical aspects of all de novo HCC in our kidney transplant recipients. Moreover, various preventive strategies which may help to optimize the outcome will also be discussed. A retrospective review of all patients who developed HCC after kidney transplantation between May 1972 and December 2011 in Hong Kong, based on the data from Hong Kong Renal Registry. After a follow-up period of 40,246 person-years, 20 patients (males 15: females 5) developed HCC. The annual incidence was 49.7/100,000 persons per year. Among them, 16 were HBV carriers, 2 were hepatitis C (HCV) carriers and 2 had HBV and HCV co-infection. Presence of HBV infection was associated with 78-fold higher risk for HCC development. Majority (85%) were asymptomatic when HCC was diagnosed by ultrasound or alpha-fetoprotein surveillance. All patients diagnosed by surveillance received active treatment while 2/3 of symptomatic patients could only receive symptomatic care and died rapidly. In conclusion, HBV infection is the major etiological factor for HCC development in kidney transplant recipients in HBV endemic areas. Regular HCC surveillance appeared to be able to detect early stage cancers which are amenable to treatment and offer the best hope of cure. 相似文献
994.
995.
996.
子痫前期(PE)是围生期母婴发病和死亡的主要原因之一。该病目前尚缺乏有效的治疗手段,终止妊娠是其唯一有效的治疗方法。预测和诊断PE的生物学标志物具有非常重要的临床意义。过去10年对PE发病机制的研究发现,生物学标志物在PE预测、诊断和治疗中发挥了重要作用。笔者总结了目前最新及最有可能用于临床预测和诊断PE的生物学标志物进行综述如下。 相似文献
997.
998.
999.
To facilitate and strengthen collaborations among cancer researchers and physicians in the United States and China, the US Chinese Anti- Cancer Association (USCACA) and the National Foundation for Cancer Research (NFCR) have established the Scholar Excellence Award for the USCACA-NFCR Scholar Exchange and Fellowship Program in Basic, Translational, and Clinical Studies. Since 2010, 10 young Chinese researchers and physicians have received the award for their outstanding achievements in cancer research accomplished while in the United States, as well as their continuing efforts in eradicating cancer after their return to China. This year, USCACA and NFCR selected 4 young scientists for their excellence in basic or clinical cancer research. Here, we are proud to introduce these 4 winners of the 2013 USCACA-NFCR Scholar Excellence Award: 相似文献
1000.